Treatment for advanced Parkinson’s disease

I reported previously (see here) on Israel’s Intec Pharma which is developing treatments based on its innovative Accordion technology.  Intec’s COO Nadav Navon provided an update of Intec’s pipeline on ILTV.  Phase 3 trials have now commenced on Intec’s Parkinson’s treatment.

https://ir.intecpharma.com/news-releases/news-release-details/intec-pharma-completes-enrollment-pivotal-phase-3-clinical-trial

https://www.youtube.com/watch?v=dQEAH5L6Ng0

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *